Pancreatic Cancer Research

ResearcherShanghai Institute of Nutrition and HealthActive in the last 2 years

Jing‐Jing Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3973-5405; OpenAlex author ID A5064704774. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. DDR1 sustains ferroptosis resistance in pancreatic ductal adenocarcinoma via SLC40A1-mediated iron homeostasis. Co-author DOI 10.1038/s41388-026-03980-w↗
  2. PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1. Last author DOI 10.1002/advs.202202448↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chao Song · 1 shared paper, 2026 · strength 0.23
  2. Wenquan Wang · 1 shared paper, 2026 · strength 0.23
  3. Yifei Zhang · 1 shared paper, 2026 · strength 0.23
  4. Yazhou Wang · 1 shared paper, 2026 · strength 0.23
  5. Taochen He · 1 shared paper, 2026 · strength 0.23
  6. Luting Zhang · 1 shared paper, 2026 · strength 0.23
  7. Wenhui Lou · 1 shared paper, 2026 · strength 0.23
  8. Liang Liu · 1 shared paper, 2026 · strength 0.23
  9. Xiao‐Fan Wang · 1 shared paper, 2023 · strength 0.12
  10. Wentao Zhou · 1 shared paper, 2023 · strength 0.12
  11. Wei Chen · 1 shared paper, 2023 · strength 0.12
  12. Qian‐Zhi Ni · 1 shared paper, 2023 · strength 0.12
  13. Shuqun Cheng · 1 shared paper, 2023 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.